These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16646004)

  • 1. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
    Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH;
    Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
    Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
    Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
    Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
    Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.
    Silva F; Seo P; Schroeder DR; Stone JH; Merkel PA; Hoffman GS; Spiera R; Sebastian JK; Davis JC; St Clair EW; Allen NB; McCune WJ; Ytterberg SR; Specks U;
    Arthritis Rheum; 2011 Aug; 63(8):2495-503. PubMed ID: 21484770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
    Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
    Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
    Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
    Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
    J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the Wegener's Granulomatosis Etanercept Trial (WGET).
    WGET Research Group
    Control Clin Trials; 2002 Aug; 23(4):450-68. PubMed ID: 12161090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Arthritis Rheum; 1999 Dec; 42(12):2666-73. PubMed ID: 10616016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.
    Lamprecht P; Gross WL
    Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.